Adma Biologics | ADMA - Net Income

Stock Price
15.81
Daily Change
0.29 1.87%
Monthly
-6.78%
Yearly
0.19%
Q1 Forecast
15.60

Adma Biologics reported $36.43M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Adma Biologics USD 36.43M 2.21M Sep/2025
Alnylam Pharmaceuticals USD 186.42M 64.66M Dec/2025
BioCryst Pharmaceuticals USD -88.88M 74.85M Dec/2024
Minerva Neurosciences USD 1.44M 21.07M Dec/2024
Novavax USD -121.3M 283.68M Sep/2024
Omeros USD -32.23M 23.81M Sep/2024
Takeda JPY 103.64B 115.44B Dec/2025